Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 118 publications
Evolving Treatment Paradigms in Hormone Receptor-Positive, Human Epidermal Growth Factor 2-Negative Metastatic Breast Cancer.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: May 19, 2026
Impact of Radionecrosis and Local Recurrence on Overall Survival After Stereotactic Radiosurgery for Brain Metastases.
Journal: Advances in radiation oncology
Published: November 26, 2025
Publisher Correction: Radiation-induced amphiregulin drives tumour metastasis.
Journal: Nature
Published: November 10, 2025
Phase 1b Study of Dazostinag plus Pembrolizumab after Hypofractionated Radiotherapy in Patients with Select Advanced Solid Tumors.
Journal: Cancer research communications
Published: September 22, 2025
Correction: Suppression of local type I interferon by gut microbiota-derived butyrate impairs antitumor effects of ionizing radiation.
Journal: The Journal of experimental medicine
Published: September 19, 2025
Erratum: De Novo Oligometastatic Breast Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 21, 2025
Radiotherapy induces YTHDF2 in dendritic cells impairing cross-presentation and T cell function.
Journal: The Journal of experimental medicine
Published: March 26, 2025
Clinical Parameters Associated With Intracranial Progression Burden Following an Initial Stereotactic Radiosurgery Course in a Multi-institutional Brain Metastases Cohort.
Journal: Advances in radiation oncology
Published: January 09, 2025
Multi-institutional Outcomes after Stereotactic Radiosurgery for Gastrointestinal Brain Metastases.
Journal: Advances in radiation oncology
Published: January 08, 2025
Impact of systemic therapy after stereotactic radiosurgery in patients with limited brain-only metastasis.
Journal: Neuro-oncology advances
Published: November 22, 2024
DARES: A Phase II Trial of Durvalumab and Ablative Radiation in Extensive-Stage Small Cell Lung Cancer.
Journal: Clinical lung cancer
Published: May 31, 2024
Safety of combined ablative radiotherapy and immune checkpoint inhibitors in three phase I trials.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 03, 2024
Last Updated: 09/26/2026